home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

PEDF, possible gene therapy candidate to prevent blindness

 
  February, 19 2001 3:47
your information resource in human molecular genetics
 
     
PEDF, protein that inhibits blood vessel growth in the eye, is licensed as possible gene therapy candidate to prevent blindness


An eye protein that blocks excessive blood vessel growth will be developed as a possible candidate for gene therapy to prevent blindness in individuals with diabetic retinopathy and macular degeneration, the leading cause of blindness in the Western world.

Contact:
Elizabeth Crown
e-crown@northwestern.edu
312-503-8928
Northwestern University


Message posted by: Wouter Kalle

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.